ArticleMolecular cancer therapeutics2025

Pan-KRAS Inhibitors BI-2493 and BI-2865 Display Potent Antitumor Activity in Tumors with KRAS Wild-type Allele Amplification.

Antonio Tedeschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.